{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:40:07Z","timestamp":1782301207186,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04208-z","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T16:20:18Z","timestamp":1755706818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy"],"prefix":"10.1186","volume":"25","author":[{"given":"Xu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"6","key":"4208_CR1","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s12072-024-10732-z","volume":"18","author":"G Lau","year":"2024","unstructured":"Lau G, Obi S, Zhou J, Tateishi R, Qin S, Zhao H, et al. APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024. Hepatol Int. 2024;18(6):1661\u201383. https:\/\/doi.org\/10.1007\/s12072-024-10732-z.","journal-title":"Hepatol Int"},{"issue":"2","key":"4208_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.21037\/hbsn-22-469","volume":"12","author":"DY Xie","year":"2023","unstructured":"Xie DY, Zhu K, Ren ZG, Zhou J, Fan J, Gao Q. A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2023;12(2):216\u201328. https:\/\/doi.org\/10.21037\/hbsn-22-469.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"14","key":"4208_CR3","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1080\/14656566.2023.2229728","volume":"24","author":"T Takamoto","year":"2023","unstructured":"Takamoto T, Maruki Y, Kondo S. Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinoma. Expert Opin Pharmacother. 2023;24(14):1567\u201375. https:\/\/doi.org\/10.1080\/14656566.2023.2229728.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"4208_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11605-012-2005-4","volume":"17","author":"A Andreou","year":"2013","unstructured":"Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 2013;17(1):66\u201377. https:\/\/doi.org\/10.1007\/s11605-012-2005-4.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"4208_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/hpb.12322","volume":"17","author":"M Brooke-Smith","year":"2015","unstructured":"Brooke-Smith M, Figueras J, Ullah S, Rees M, Vauthey JN, Hugh TJ, et al. Prospective evaluation of the international study group for liver surgery definition of bile leak after a liver resection and the role of routine operative drainage: an international multicentre study. HPB. 2015;17(1):46\u201351. https:\/\/doi.org\/10.1111\/hpb.12322.","journal-title":"HPB"},{"issue":"2","key":"4208_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaccao.2022.05.002","volume":"4","author":"DY Chen","year":"2022","unstructured":"Chen DY, Liu JR, Tseng CN, Hsieh MJ, Chuang CK, Pang ST, et al. Major adverse cardiovascular events in patients with renal cell carcinoma treated with targeted therapies. JACC CardioOncology. 2022;4(2):223\u201334. https:\/\/doi.org\/10.1016\/j.jaccao.2022.05.002.","journal-title":"JACC CardioOncology"},{"issue":"24","key":"4208_CR7","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1111\/febs.12042","volume":"279","author":"DN Patil","year":"2012","unstructured":"Patil DN, Chaudhary A, Sharma AK, Tomar S, Kumar P. Structural basis for dual inhibitory role of tamarind Kunitz inhibitor (TKI) against factor Xa and trypsin. FEBS J. 2012;279(24):4547\u201364. https:\/\/doi.org\/10.1111\/febs.12042.","journal-title":"FEBS J"},{"issue":"1","key":"4208_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1055\/s-0041-1730312","volume":"122","author":"BME Tullemans","year":"2022","unstructured":"Tullemans BME, Fern\u00e1ndez DI, Veninga A, Baaten C, Peters LJF, Aarts MJB, et al. Tyrosine kinase inhibitor Sunitinib delays Platelet-Induced coagulation: additive effects of aspirin. Thromb Haemost. 2022;122(1):92\u2013104. https:\/\/doi.org\/10.1055\/s-0041-1730312.","journal-title":"Thromb Haemost"},{"issue":"5","key":"4208_CR9","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1002\/hep.32019","volume":"74","author":"P Jepsen","year":"2021","unstructured":"Jepsen P, Tapper EB, Deleuran T, Kazankov K, Askgaard G, S\u00f8rensen HT, et al. Risk and outcome of venous and arterial thrombosis in patients with cirrhosis: a Danish nation-wide cohort study. Hepatology. 2021;74(5):2725\u201334. https:\/\/doi.org\/10.1002\/hep.32019.","journal-title":"Hepatology"},{"issue":"2","key":"4208_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJMra1011170","volume":"365","author":"A Tripodi","year":"2011","unstructured":"Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147\u201356. https:\/\/doi.org\/10.1056\/NEJMra1011170.","journal-title":"N Engl J Med"},{"issue":"11","key":"4208_CR11","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1111\/jth.13814","volume":"15","author":"BJ Kim","year":"2017","unstructured":"Kim BJ, Day RW, Davis CH, Narula N, Kroll MH, Tzeng CWD, et al. Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective. J Thromb Haemost. 2017;15(11):2158\u201364. https:\/\/doi.org\/10.1111\/jth.13814.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"4208_CR12","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1111\/jth.15060","volume":"18","author":"S Bos","year":"2020","unstructured":"Bos S, van den Boom B, Ow TW, Prachalias A, Adelmeijer J, Phoolchund A, et al. Efficacy of pro- and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery. J Thromb Haemostasis: JTH. 2020;18(11):2840\u201351. https:\/\/doi.org\/10.1111\/jth.15060.","journal-title":"J Thromb Haemostasis: JTH"},{"key":"4208_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrac142","author":"E Sparrelid","year":"2022","unstructured":"Sparrelid E, Olthof PB, Dasari BVM, Erdmann JI, Santol J, Starlinger P, et al. Current evidence on posthepatectomy liver failure: comprehensive review. BJS Open. 2022. https:\/\/doi.org\/10.1093\/bjsopen\/zrac142.","journal-title":"BJS Open"},{"key":"4208_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001156","author":"YX Gan","year":"2024","unstructured":"Gan YX, Yang ZL, Pan YX, Ou-Yang LY, Tang YH, Zhang YJ, et al. Change of indocyanine green clearance ability and liver function after transcatheter intraarterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study. Int J Surg (London England). 2024. https:\/\/doi.org\/10.1097\/JS9.0000000000001156.","journal-title":"Int J Surg (London England)"},{"issue":"8","key":"4208_CR15","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1182\/bloodadvances.2022007169","volume":"7","author":"TJ Zheng","year":"2023","unstructured":"Zheng TJ, Kohs TCL, Mueller PA, Pang J, Reitsma SE, Parra-Izquierdo I, Melrose AR, Yang L, Choi J, Zientek KD, Sviridov DO, Larson MK, Williams CD, Pamir N, Shatzel JJ, Reddy AP, Kievit P, Remaley AT, Stevens JF, Hinds MT, McCarty OJT, Aslan JE. Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity. Blood Adv. 2023;7(8):1366\u201378. https:\/\/doi.org\/10.1182\/bloodadvances.2022007169.","journal-title":"Blood Adv"},{"issue":"1","key":"4208_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00280-024-04741-w","volume":"95","author":"MT Sato","year":"2024","unstructured":"Sato MT, Araki T, Yashima H, Ishikawa Y, Morita J, Maeda Y, Ohbayashi M, Kohyama N, Ogawa Y, Fukagai T, Yamamoto K, Kogo M. Variations in serum concentrations of Sunitinib and its metabolites in patients receiving long-term Sunitinib treatment. Cancer Chemother Pharmacol. 2024;95(1):14. https:\/\/doi.org\/10.1007\/s00280-024-04741-w.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"4208_CR17","doi-asserted-by":"publisher","first-page":"e0304782","DOI":"10.1371\/journal.pone.0304782","volume":"19","author":"SJ Bakri","year":"2024","unstructured":"Bakri SJ, Lynch J, Howard-Sparks M, Saint-Juste S, Saim S. Vorolanib, sunitinib, and axitinib: A comparative study of vascular endothelial growth factor receptor inhibitors and their anti-angiogenic effects. PLoS ONE. 2024;19(6):e0304782. https:\/\/doi.org\/10.1371\/journal.pone.0304782.","journal-title":"PLoS ONE"},{"key":"4208_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijcard.2021.09.017","volume":"344","author":"X Wang","year":"2021","unstructured":"Wang X, Bai L, Liu X, Shen W, Tian H, Liu W, Yu B. Cardiac microvascular functions improved by MSC-derived exosomes attenuate cardiac fibrosis after ischemia-reperfusion via PDGFR-\u03b2 modulation. Int J Cardiol. 2021;344:13\u201324. https:\/\/doi.org\/10.1016\/j.ijcard.2021.09.017.","journal-title":"Int J Cardiol"},{"issue":"7","key":"4208_CR19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/liv.15609","volume":"43","author":"A Pasta","year":"2023","unstructured":"Pasta A, Calabrese F, Labanca S, Marenco S, Pieri G, Plaz Torres MC, Intagliata NM, Caldwell SH, Giannini EG. Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: a systematic review and meta-analysis. Liver Int. 2023;43(7):1399\u2013406. https:\/\/doi.org\/10.1111\/liv.15609.","journal-title":"Liver Int"},{"key":"4208_CR20","doi-asserted-by":"publisher","first-page":"8859602","DOI":"10.1155\/2021\/8859602","volume":"2021","author":"H Chen","year":"2021","unstructured":"Chen H, Lei J, Liang S, Luo G, Deng M, L\u00fc M. Safety and efficacy of anticoagulation in patients with cirrhosis: A Meta-Analysis. Can J Gastroenterol Hepatol. 2021;2021:8859602. https:\/\/doi.org\/10.1155\/2021\/8859602.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"3","key":"4208_CR21","first-page":"678","volume":"108","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. Pharmacokinetics of Enoxaparin in patients with liver cirrhosis. Clin Pharmacol Ther. 2020;108(3):678\u201386.","journal-title":"Clin Pharmacol Ther"},{"issue":"15 suppl","key":"4208_CR22","first-page":"4012","volume":"37","author":"Z Li","year":"2019","unstructured":"Li Z, et al. Dosing of low molecular weight heparin in obese cancer patients: A Pharmacokinetic study. J Clin Oncol. 2019;37(15 suppl):4012.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4208_CR23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11239-021-02621-1","volume":"54","author":"X Zhang","year":"2022","unstructured":"Zhang X, Liu J, Zhao X, et al. Pharmacologic thromboprophylaxis in hepatobiliary surgery: A meta-analysis of randomized controlled trials. J Thromb Thrombolysis. 2022;54(1):132\u201343.","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"4208_CR24","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/archinte.165.10.1173","volume":"165","author":"SR Kahn","year":"2005","unstructured":"Kahn SR, Ducruet T, Lamping DL, et al. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med. 2005;165(10):1173\u20138.","journal-title":"Arch Intern Med"},{"issue":"2","key":"4208_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gut.45.2.295","volume":"45","author":"ZM Younossi","year":"1999","unstructured":"Younossi ZM, Guyatt G, Kiwi M, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45(2):295\u2013300.","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04208-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04208-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04208-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:24:43Z","timestamp":1757409883000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04208-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4208"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04208-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Huizhou Central People\u2019s Hospital. The procedures were conducted in accordance with the ethical standards set forth by the Committee on Human Experimentation and the Helsinki Declaration of 1964, as revised in 2013. Informed consent was waived by the Ethics Committee of Huizhou Central People\u2019s Hospital for this retrospective study due to the exclusive use of de-identified patient data, which posed no potential harm or impact on patient care. This waiver was approved by the institutional review board and ethics committee of our institution in accordance with regulatory and ethical guidelines pertaining to retrospective studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"606"}}